Midaflur, an imidazoline derivative, was developed as an anesthetic agent. This drug acted as a central skeletal muscle relaxant and showed sedative properties. Preclinical experiments have shown that midaflur had minimal effects at high doses in cardiovascular studies. In addition, it was inactive in anti-inflammatory, diuretic, and plasma glucose studies. Information about the current use of this compound is not available.